NYSE
OHI
Last Price
US $48.17
KEY FIGURES
MKT CAP
$14.3B
EPS
TTM
$2.13
PEG
TTM
0.74x
P/E
TTM
22.46x
P/S
TTM
11.95x
YIELD
5.58%
GROWTH
Revenue Y/Y
6.07%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $48.17
-33.67%
Default assumptions
EBITDA Multiple
Fair Value
Market $48.17
-72.16%
Default assumptions
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Omega Healthcare Investors, Inc. cash flow to debt ratio of 20.64% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Omega Healthcare Investors, Inc.'s free cash flow has increased 23.27% from $712.69M last year to $878.55M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Omega Healthcare Investors, Inc.'s debt to equity ratio is 0.86, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial stability - Healthy debt to equity ratio development.
Omega Healthcare Investors, Inc.'s debt has decreased relative to shareholder equity from 1.07 last year to 0.86 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
Omega Healthcare Investors, Inc. has a net debt to EBITDA ratio of 3.61x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
Omega Healthcare Investors, Inc.'s interest coverage ratio of 3.75 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Omega Healthcare Investors, Inc.'s profit margin has increased (32.02%) in the last year from 38.65% to 51.02%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Omega Healthcare Investors, Inc.'s short-term assets of $2.06G exceed its short-term liabilities of $594.55M
Increasing performance - ROA.
Omega Healthcare Investors, Inc.'s return on assets of 6.18% is higher than the 5.00% threshold, indicating efficient asset utilization
Decreasing performance - Absolute return on equity.
Omega Healthcare Investors, Inc.'s return on equity of 12.40%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Omega Healthcare Investors, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Omega Healthcare Investors, Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Omega Healthcare Investors, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Omega Healthcare Investors, Inc. has a free cash flow yield of 6.14%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Omega Healthcare Investors, Inc.'s yearly earnings has increased 45.23% since last year from $406.33M to $590.11M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Omega Healthcare Investors, Inc.'s yearly revenue has increased 13.19% since last year from $1.05G to $1.19G, signaling increasing performance
Increasing performance - ROIC.
ROIC 7.86% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
Omega Healthcare Investors, Inc.'s 3-year revenue CAGR of 10.91% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Omega Healthcare Investors, Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Omega Healthcare Investors, Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Omega Healthcare Investors, Inc. is overvalued relative to its fair value price of 31.95 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Omega Healthcare Investors, Inc. has an earnings yield of 4.43%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Omega Healthcare Investors, Inc. is overvalued relative to its fair value price of 13.41 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Omega Healthcare Investors, Inc. has an EV/EBITDA ratio of 15.42x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Omega Healthcare Investors, Inc. has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Omega Healthcare Investors, Inc. has a price-to-book ratio of 2.75x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Overvalued - P/S ratio.
Omega Healthcare Investors, Inc. has a price-to-sales ratio of 11.55x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
12.40%
Return on equity
ROIC: 7.86%
Valuation History
22.5X
Price to Earnings
EV/EBITDA: 15.4X
Cash flow
Profit margin
10.33%
(FY vs FY)
Cash flow Y/Y
6.77%
(FY vs FY)
Base valuations use default assumptions. Customize in the Valuator.